Viola Tricolor

Dosage for Viola Tricolor allergenic extracts is highly individualized and is never based on a "one size fits all" approach. Instead, dosage is measured in Protein Nitrogen Units (PNU) or weight/volume (w/v) dilutions.

Diagnostic Testing

• Skin Prick Test: Usually, a single drop of a 1:10 or 1:20 w/v extract is applied to the skin.
• Intradermal Test: If the skin prick test is negative but clinical suspicion remains high, a healthcare provider may inject 0.02 mL to 0.05 mL of a highly diluted extract (e.g., 100 PNU/mL or 1:1000 w/v) into the skin layers.

Immunotherapy (Allergy Shots)

• Build-up Phase: Injections typically start at a very low dose (e.g., 0.1 mL of a 1:100,000 w/v dilution) once or twice weekly. The dose is gradually increased over 3 to 6 months.
• Maintenance Phase: Once the "top dose" is reached (e.g., 0.5 mL of a 1:100 or 1:10 w/v dilution), the frequency is reduced to once every 2 to 4 weeks.

Viola Tricolor extracts may be used in children, but extreme caution is required.

• Age Considerations: Immunotherapy is generally not started in children under the age of 5 because they may be unable to communicate the early symptoms of a systemic reaction.
• Dosing: The dosing schedule for children is typically the same as for adults, but the physician may choose a more conservative build-up phase to monitor for adverse effects.
• Safety: Clinical studies have shown that pediatric patients are at a slightly higher risk for local reactions, but systemic reactions occur at similar rates to adults.

Renal Impairment

No specific dose adjustments are required for patients with kidney disease, as the proteins are metabolized by proteases rather than being primarily cleared by the kidneys in their active form.

Hepatic Impairment

No dose adjustments are necessary for patients with liver disease.

Elderly Patients

Older adults (over 65) may be at higher risk if they have underlying cardiovascular disease. Healthcare providers will assess if the patient can tolerate the potential stress of a systemic reaction or the administration of epinephrine before starting treatment.

Viola Tricolor allergenic extracts must ONLY be administered by a trained healthcare professional in a clinical setting equipped to handle anaphylaxis.

• Administration Site: Injections for immunotherapy are given subcutaneously (just under the skin) in the outer aspect of the upper arm.
• Observation Period: You MUST remain in the doctor's office for at least 30 minutes after every injection. Most fatal reactions to allergenic extracts occur within this timeframe.
• Site Care: Do not rub or massage the injection site, as this can increase the rate of absorption and the risk of a reaction.
• Storage: If you are transporting your own extract vials, they must be kept refrigerated between 2°C and 8°C (36°F to 46°F). Do not freeze.

In immunotherapy, consistency is vital for safety.

• If you miss a dose during the build-up phase, your doctor may need to repeat the previous dose or even reduce the dose depending on how much time has passed.
• If you miss a dose during the maintenance phase by more than 1-2 weeks, the dose is usually reduced to prevent a reaction when you restart.
• Never attempt to "double up" on doses to catch up.

An overdose of Viola Tricolor extract typically manifests as a severe systemic allergic reaction.

• Signs: Hives (urticaria), swelling of the throat (angioedema), wheezing, shortness of breath, rapid heart rate, or a sudden drop in blood pressure (fainting).
• Emergency Measures: If an overdose occurs in the clinic, the provider will immediately administer epinephrine (adrenaline), oxygen, and possibly intravenous fluids or antihistamines.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your schedule or attempt to self-administer these extracts.

Most patients receiving Viola Tricolor extracts will experience some form of local reaction. These are generally not dangerous but indicate the body is responding to the allergen.

• Local Redness (Erythema): The area around the injection or test site becomes red and warm to the touch. This usually appears within minutes and fades within a few hours.
• Itching (Pruritus): Intense itching at the site of administration is very common. This can be managed with cool compresses or oral antihistamines if recommended by your doctor.
• Swelling (Wheal): A raised, soft bump at the injection site. A "normal" local reaction is typically smaller than the size of a half-dollar (approx. 3 cm).

• Large Local Reactions (LLR): Swelling that exceeds 5-10 cm in diameter. This may be accompanied by pain and stiffness in the arm. These reactions often peak 6 to 12 hours after the injection.
• Fatigue: Some patients report feeling unusually tired or "flu-like" for several hours following an immunotherapy session.
• Headache: Mild to moderate tension-type headaches have been reported.

• Generalized Hives: Itchy bumps appearing on parts of the body far away from the injection site.
• Nasal Congestion and Sneezing: A temporary flare-up of hay fever symptoms.
• Mild Wheezing: A slight tightening of the chest, particularly in patients with a history of asthma.

> Warning: Stop taking Viola Tricolor immunotherapy and call your doctor or emergency services immediately if you experience any of the following symptoms of anaphylaxis.

• Upper Airway Obstruction: Feeling of a "lump in the throat," hoarseness, or difficulty swallowing.
• Lower Airway Obstruction: Severe wheezing, chest tightness, or persistent coughing.
• Cardiovascular Collapse: Dizziness, fainting, rapid or weak pulse, and a sharp drop in blood pressure.
• Angioedema: Significant swelling of the lips, tongue, or face that may interfere with breathing.
• Gastrointestinal Distress: Sudden, severe abdominal cramping, vomiting, or diarrhea occurring shortly after an injection.

• Subcutaneous Nodules: In rare cases, a small, hard lump (granuloma) may form under the skin at the site of repeated injections. These are usually harmless but should be monitored.
• Persistent Sensitization: While the goal is desensitization, some patients may find their sensitivity temporarily increases if the dose is escalated too quickly.

While Viola Tricolor specifically may not have a unique individual black box warning, all Allergenic Extracts as a class carry a standard FDA-mandated warning regarding the risk of severe systemic reactions.

Summary of Warning: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. They should only be administered by physicians who are exceptionally experienced in the treatment of allergic diseases and the management of systemic reactions. Patients must be observed for at least 30 minutes in the office after administration. Patients with unstable asthma or those taking beta-blockers may be at increased risk for severe outcomes.

Report any unusual symptoms, even if they seem minor, to your healthcare provider immediately.

Viola Tricolor allergenic extracts are biological products that carry inherent risks. Safety is dependent on proper administration, patient selection, and rigorous monitoring. Patients must be in their baseline state of health (no active infections or asthma flares) before receiving an injection.

No specific individual FDA black box warning exists for Viola Tricolor specifically, but it falls under the Class Warning for Allergenic Extracts:

• Risk of Anaphylaxis: This product can cause life-threatening allergic reactions.
• Supervision: Must be administered in a facility with emergency equipment (epinephrine, airway management tools).
• Observation: A 30-minute mandatory wait time post-injection is required.

Allergic Reactions / Anaphylaxis Risk

The primary risk is a systemic allergic reaction. This risk is higher during the "build-up" phase of immunotherapy, during high pollen seasons, or if the patient has had a recent viral infection.

Asthma Status

Patients with uncontrolled or unstable asthma are at the highest risk for fatal reactions to allergenic extracts. If your peak flow meter reading is significantly below your personal best, or if you are using your rescue inhaler more frequently, you must notify your doctor before receiving a Viola Tricolor injection.

Cardiovascular Disease

Patients with significant heart disease may not be able to tolerate the physiological stress of anaphylaxis or the side effects of the treatment for it (epinephrine). A thorough cardiac evaluation is necessary for these patients before starting therapy.

Unlike many drugs, Viola Tricolor does not require routine blood counts or liver function tests. Instead, monitoring involves:

• Symptom Tracking: Keeping a log of any local or systemic reactions after each dose.
• Peak Flow Monitoring: For asthmatic patients, measuring lung function before each injection.
• Vital Signs: Checking blood pressure and pulse if the patient feels unwell after administration.

Generally, Viola Tricolor does not cause sedation. However, if you experience a systemic reaction or feel lightheaded/fatigued after your injection, you should avoid driving or operating heavy machinery until the symptoms have completely resolved.

There is no direct chemical interaction between alcohol and Viola Tricolor extracts. However, alcohol can cause vasodilation (widening of blood vessels), which may theoretically increase the speed of allergen absorption and the severity of a reaction. It is best to avoid alcohol for several hours before and after your injection.

Immunotherapy can be stopped at any time without "withdrawal" symptoms. However, the benefits of the treatment (allergy reduction) will gradually fade. If you stop for several weeks and wish to restart, you cannot return to your previous dose; you must be re-evaluated by your doctor to determine a safe starting point.

> Important: Discuss all your medical conditions, especially respiratory or heart problems, with your healthcare provider before starting Viola Tricolor.

Beta-Blockers (e.g., Propranolol, Metoprolol, Atenolol)

• Mechanism: These drugs block the beta-adrenergic receptors that epinephrine (adrenaline) needs to bind to in order to work.
• Clinical Consequence: If you have a severe allergic reaction to Viola Tricolor, the emergency treatment (epinephrine) may be ineffective. This can lead to fatal anaphylaxis.
• Management: Patients on beta-blockers are generally not candidates for allergen immunotherapy unless the benefits overwhelmingly outweigh the risks and no alternative exists.

ACE Inhibitors (e.g., Lisinopril, Enalapril)

• Mechanism: ACE inhibitors can interfere with the body's ability to break down kinins, which are involved in allergic inflammation.
• Clinical Consequence: May increase the risk or severity of systemic reactions.
• Management: Use with caution; your doctor may monitor you more closely during the build-up phase.

Tricyclic Antidepressants (TCAs) and MAOIs

• Mechanism: These drugs can potentiate the effects of epinephrine, leading to dangerously high blood pressure if an emergency injection is needed.
• Management: Inform your allergist if you are taking medications for depression or anxiety.

Antihistamines (e.g., Loratadine, Cetirizine, Diphenhydramine)

• Mechanism: These drugs block the H1 receptors, masking the "wheal and flare" reaction.
• Clinical Consequence: During diagnostic testing, antihistamines will cause a false-negative result (the test will show no allergy even if one exists).
• Management: You must stop taking most antihistamines for 3 to 7 days before skin testing. However, they are often continued during immunotherapy to reduce the discomfort of local reactions.

There are no known direct food interactions with Viola Tricolor extracts. However, patients with "Oral Allergy Syndrome" may experience cross-reactivity between certain botanical allergens and fruits/vegetables. Discuss any food allergies with your doctor.

St. John’s Wort

• While not a direct interaction, St. John's Wort can increase photosensitivity. Since Viola Tricolor is also used in some herbal skin preparations, the combination might increase skin irritation risk.

Viola Tricolor extracts do not typically interfere with standard blood chemistry or hematology tests. However, they will directly affect:

• Skin Prick Tests: As intended, they will cause a positive result.
• Serum IgE Tests (ImmunoCAP): Successful immunotherapy will eventually lead to changes in your specific IgE and IgG4 levels for Viola Tricolor.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or heart health.

Viola Tricolor allergenic extracts must NEVER be used in the following circumstances:

1. 1Severe, Uncontrolled Asthma: If a patient's asthma is not well-managed with daily controller medications, the risk of a fatal bronchospasm during a reaction is too high. The mechanism involves the allergen triggering a systemic inflammatory cascade that the compromised lungs cannot tolerate.
2. 2Recent Myocardial Infarction (Heart Attack): Within the last 3-6 months. The heart must be stable enough to handle the potential tachycardia (fast heart rate) and hypotension (low blood pressure) of a systemic reaction.
3. 3History of Life-Threatening Anaphylaxis to this Specific Extract: If a patient has previously had a near-fatal reaction to Viola Tricolor, the risk of re-administration usually outweighs any diagnostic or therapeutic benefit.

These conditions require a careful risk-benefit analysis by a specialist:

• Pregnancy: Immunotherapy is generally not started during pregnancy due to the risk of anaphylaxis-induced fetal hypoxia (lack of oxygen). However, if a woman is already on a stable maintenance dose and becomes pregnant, the treatment may sometimes be continued.
• Autoimmune Diseases: There is a theoretical risk that stimulating the immune system with allergens could worsen certain autoimmune conditions.
• Malignancy: Patients with active cancer may have altered immune responses.
• Eczema (Severe): While Viola Tricolor is used to treat mild eczema in herbalism, severe flares of atopic dermatitis can make skin testing impossible to interpret.

Patients who are allergic to other members of the Violaceae family (such as common garden violets) may show cross-sensitivity to Viola Tricolor. Additionally, because many allergenic extracts are prepared in a similar manner, a patient with a known severe allergy to the preservatives used in the vials (such as phenol or glycerin) should not receive the extract.

> Important: Your healthcare provider will evaluate your complete medical history, including heart and lung health, before prescribing Viola Tricolor.

FDA Pregnancy Category C (based on class data for allergenic extracts).

• Risk Summary: There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted.
• Clinical Considerations: The primary danger to the fetus is maternal anaphylaxis, which can lead to a sudden drop in blood pressure and uterine blood flow, causing fetal distress or death.
• Recommendation: Most allergists will not initiate Viola Tricolor immunotherapy during pregnancy. If a patient is already on a maintenance dose, the dose is usually not increased until after delivery.

It is not known whether the allergenic components of Viola Tricolor are excreted in human milk. However, because these are large proteins that are likely broken down in the mother's gastrointestinal tract if they were ingested, the risk to a nursing infant is considered extremely low. The benefits of breastfeeding should be weighed against the clinical need for the mother's treatment.

• Approval: Viola Tricolor is used in pediatric allergy diagnostics.
• Safety: As noted previously, children under 5 are often excluded from immunotherapy because they cannot adequately describe the early onset of systemic symptoms (e.g., "my throat feels itchy").
• Growth: There is no evidence that allergenic extracts affect growth or development in children.

Clinical studies of allergenic extracts generally do not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently than younger subjects.

• Risks: Older patients are more likely to have co-morbidities like hypertension or coronary artery disease, making them poorer candidates for managing a systemic reaction.
• Renal/Hepatic: No specific concerns related to organ clearance.

No dosage adjustment is required. The protein components are not cleared as intact active drugs by the kidneys. However, patients with end-stage renal disease (ESRD) should be monitored for overall fluid balance if they require emergency treatment for a reaction.

No dosage adjustment is required. The liver's CYP450 system is not involved in the processing of these allergenic proteins.

> Important: Special populations require individualized medical assessment. Always inform your specialist about pregnancy or other health changes.

Viola Tricolor acts as an immunomodulator. At the molecular level, the extract contains specific proteins (antigens) that have a high affinity for IgE antibodies.

1. 1Sensitization Phase: In allergic individuals, B-cells have already produced IgE specific to Viola Tricolor proteins. These IgE molecules are "docked" on the FcεRI receptors of mast cells and basophils.
2. 2Effector Phase: When the extract is administered, the antigens cross-link two adjacent IgE molecules. This cross-linking sends a signal into the mast cell, causing it to release pre-formed granules containing histamine and heparin, and to begin synthesizing new mediators like leukotrienes.
3. 3Tolerance Phase: During immunotherapy, repeated exposure leads to the expansion of T-regulatory (Treg) cells that secrete IL-10 and TGF-beta, which suppress the Th2-driven allergic response.

• Onset of Action: For skin testing, the onset is 15–20 minutes. For immunotherapy, clinical improvement in symptoms usually takes 3 to 6 months of consistent treatment.
• Duration of Effect: A single skin test reaction lasts 1–2 hours. The effects of a full course of immunotherapy (3-5 years) can persist for many years after discontinuation.
• Tolerance: Unlike many drugs where tolerance means reduced effect, in allergy, "tolerance" is the desired therapeutic goal (the body stops overreacting).

| Parameter | Value |

|---|---|

| Bioavailability | Low (Percutaneous); Moderate (Subcutaneous) |

| Protein Binding | N/A (Biological Protein) |

| Half-life | Variable (Proteins degraded within hours) |

| Tmax | 15-30 minutes (Local) |

| Metabolism | Proteolysis (Protease enzymes) |

| Excretion | Renal (as amino acids/metabolites) |

• Molecular Composition: A complex mixture of proteins, glycoproteins, and secondary metabolites including salicylic acid, tannins, and flavonoids (specifically rutin).
• Cyclotides: Viola Tricolor is known for containing "cyclotides" (e.g., Vitri A), which are circular proteins that are exceptionally stable and have shown potential anti-tumor and anti-inflammatory properties in laboratory settings.
• Solubility: The allergenic proteins are soluble in aqueous solutions and stabilized in 50% glycerin for commercial use.

Viola Tricolor is classified as a Standardized or Non-Standardized Plant Allergenic Extract. It belongs to the broader therapeutic category of Biologicals / Immunomodulators. It is related to other botanical allergens such as Ragweed, Timothy Grass, and Oak extracts.